| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 56.68B | 57.56B | 57.20B | 57.52B | 53.00B | 42.57B |
| Gross Profit | 10.21B | 10.32B | 9.85B | 10.24B | 11.29B | 7.81B |
| EBITDA | 3.66B | 3.93B | 4.01B | 5.07B | 6.66B | 4.07B |
| Net Income | 1.60B | 1.82B | 1.54B | 381.00M | 2.69B | 268.00M |
Balance Sheet | ||||||
| Total Assets | 82.72B | 83.76B | 80.61B | 79.89B | 82.00B | 75.57B |
| Cash, Cash Equivalents and Short-Term Investments | 17.44B | 19.66B | 16.31B | 18.61B | 19.55B | 15.19B |
| Total Debt | 6.53B | 7.23B | 1.17B | 1.87B | 2.65B | 2.95B |
| Total Liabilities | 18.66B | 17.43B | 14.14B | 13.34B | 15.14B | 12.86B |
| Stockholders Equity | 57.31B | 59.54B | 60.01B | 59.39B | 59.65B | 56.23B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.45B | 1.91B | 2.65B | 5.35B | 2.56B |
| Operating Cash Flow | 0.00 | 4.11B | 4.19B | 3.89B | 6.33B | 3.97B |
| Investing Cash Flow | 0.00 | -3.40B | -1.65B | -1.20B | -40.00M | -758.00M |
| Financing Cash Flow | 0.00 | 1.71B | -5.08B | -4.29B | -1.97B | -1.59B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥72.42B | 8.43 | ― | 5.15% | -9.28% | -7.18% | |
70 Outperform | ¥103.26B | 10.61 | ― | 3.70% | -3.06% | 1.15% | |
67 Neutral | ¥37.68B | 18.59 | ― | 4.64% | -5.13% | 18.49% | |
64 Neutral | ¥34.59B | -185.54 | ― | 5.02% | -13.64% | -45.74% | |
64 Neutral | ¥53.76B | 7.67 | ― | 6.27% | -7.45% | -9.12% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | ¥80.15B | 53.99 | ― | 1.24% | -12.05% | -97.36% |